Vaccines, Scientific Breakthroughs and Mopping Floors with Jessica Flechtner

In this Innovation Ecosystem podcast, Dr. Jessica Flechtner of Genocea Biosciences discusses her journey progressing the company from startup to going public. Learn from Jessica’s journey and rationale for joining an innovative biosciences startup despite her illustrious research career; her key role in bringing a company from the acquisition of venture capital funding through to going public in year and how she and the Genocea team create a culture of discussing failure and celebrating success that helps them maintain their competitive edge in an ever-changing and demanding pharmaceutical industry.

Welcome to this week’s episode of the Innovation Ecosystem podcast with remarkable and thought-provoking interviews about innovation, leadership and change in the world of business.

Visit InnovationEcosystem.com to subscribe, download the full transcript for this episode, additional resources and more.

.

Listen to ‘Vaccines, Scientific Breakthroughs and Mopping Floors’ with Jessica Flechtner

Jessica Baker Flechtner, Ph.D. joined Genocea in 2007, soon after the company was founded, and currently serves as the Chief Scientific Officer. Dr. Flechtner is a pioneer in the development of novel vaccines directed toward T cell immunity, and has more than 20 years of experience in immunology, infectious disease, cancer, and vaccine development. She leads Genocea’s efforts to develop T cell-directed vaccines and immunotherapies against infectious diseases and other indications. Prior to joining Genocea, Dr. Flechtner developed vaccines and immunotherapies for cancer, infectious disease, autoimmunity and allergy in several companies including Mojave Therapeutics and Antigenics Inc. (now Agenus). She is an inventor on ten pending and four issued patents and has multiple peer-reviewed scientific publications. Dr. Flechtner performed her post-doctoral work at the Dana Farber Cancer Institute and Harvard Medical School. She holds a Ph.D. in Cellular Immunology and a B.S. in Animal Science from Cornell University, and is a member of the American Association of Immunologists, American Association for Cancer Research, Society for Immunotherapy of Cancer, and American Society for Microbiology.

Jessica is also a member of the prestigious 40 women over 40 for her passion project to encourage more young women to embark on careers in STEM.

 

Mark Bidwell has extensive experience catalyzing and driving change in a variety of marketing and leadership roles at market-leading companies such as BP Oil, The Hay Group, and Syngenta, where I lhe the creation and development of a $2bn Specialty Crops business unit. Mark’s initial exposure to disruptive innovation involved launching London’s first home-delivery supermarket, followed by introducing the first web-based consulting product to European clients in 1995, which formed the basis of a business that today generates revenues approaching $150m.

Through the innovation ecosystem show, Mark brings you key insights, fresh perspectives, and proven tools you can use straight away to make you more successful professionally and personally. For more information, please visit markbidwell.com or email mark@innovationecosystem.com.

Ad

STAY CONNECTED

 
Ad